[Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine]
- PMID: 11798797
[Comparison of immunology effects between live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine]
Abstract
Objective: To study the immunology effects of live attenuated hepatitis A vaccine in different doses and schedules groups, and compare with inactivated hepatitis A vaccine (Havrix, Smithkline).
Methods: 318 susceptible children were enrolled in Guangxi and Hebei province. These subjects were divided into six groups. Each group was vaccinated with either inactivated vaccine or different doses and schedules of live attenuated vaccine. Serum specimens were collected and tested for anti-HAV antibody at different time after the vaccination.
Results: GMT of each group arrived at the peak 1 months after re-vaccination, then declined, and GMT of 6 months after booster dose was still significantly higher than that after primary immunization. Sero-conversion rates in all groups reached 100% after a booster dose, and kept at 6 months after booster dose.
Conclusions: A booster dose of live attenuated vaccine can induce secondary immune response well. The immunology effects after booster dose are comparable with inactivated vaccine and it should be useful to the immune persistence.
Similar articles
-
[Primary study on immunologic effect of live attenuated hepatitis A vaccine (H2 strain) after booster dose].Zhonghua Liu Xing Bing Xue Za Zhi. 2000 Apr;21(2):124-7. Zhonghua Liu Xing Bing Xue Za Zhi. 2000. PMID: 11860772 Clinical Trial. Chinese.
-
Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.Southeast Asian J Trop Med Public Health. 2000 Mar;31(1):29-36. Southeast Asian J Trop Med Public Health. 2000. PMID: 11023061 Clinical Trial.
-
Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up.Vaccine. 2007 Jan 5;25(3):446-9. doi: 10.1016/j.vaccine.2006.08.004. Epub 2006 Aug 17. Vaccine. 2007. PMID: 16949710 Clinical Trial.
-
[Vaccination against hepatitis A].Recenti Prog Med. 1992 Jun;83(6):313-20. Recenti Prog Med. 1992. PMID: 1323136 Review. Italian.
-
Hepatitis A vaccine.Am J Gastroenterol. 1996 Feb;91(2):217-22. Am J Gastroenterol. 1996. PMID: 8607483 Review.
Cited by
-
Live attenuated hepatitis A vaccines developed in China.Hum Vaccin Immunother. 2014;10(3):659-66. doi: 10.4161/hv.27124. Epub 2013 Nov 26. Hum Vaccin Immunother. 2014. PMID: 24280971 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical